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Abstract
Background: The PORMETS study was designed to estimate the prevalence of metabolic syndrome and its
determinants in the overall and administrative regions of the Portuguese mainland.
Methods: A cross-sectional study of a representative sample of non-institutionalized Portuguese adults selected from
primary health care centres lists including 1695 men and 2309 women was conducted from February 2007 to July 2009.
A structured questionnaire was administered, collecting information on personal medical history and socio-demographic
and behavioural characteristics. Anthropometrics, blood pressure, and venous blood samples were obtained. Metabolic
syndrome was defined according to three operational definitions. The prevalence ratios and their respective 95%
confidence intervals were calculated using binomial generalized linear regression, with the log link function.
Results: The prevalence rates of metabolic syndrome in this sample of Portuguese adults were 36.5%, 49.6%, and 43.1%,
using the Adult Treatment Panel III, International Diabetes Federation and Joint Interim Statement definitions, respectively.
The most prevalent feature of metabolic syndrome in this sample was high blood pressure (64.3%) and the lowest was
high fasting glucose (24.9%). After adjustment for age and gender, significant differences were observed for the 18
districts of the Portugal mainland. Additionally, metabolic syndrome was significantly more frequent in non-urban areas
than in urban ones (p = 0.001). The prevalence of metabolic syndrome was significantly higher in women (p˂0.001) and
older participants (p˂0.001), as well as in those who reported being housewives (p = 0.010), retired (p = 0.046) or
unemployed (p = 0.024).
Conclusions: This study showed that metabolic syndrome is highly prevalent in the Portuguese adult population.
Regional differences in the prevalence of this syndrome were observed, and this condition was more common in non-
urban areas and less favoured socio-economic categories.
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Background
Metabolic syndrome (MetS) is a cluster of interrelated risk
factors for cardiovascular disease (CVD) [1] and diabetes
[2]. These factors include dysglycaemia, elevated blood
pressure, elevated triglyceride levels, low high-density lipo-
protein cholesterol (HDL-C) levels, and central obesity. Dif-
ferent organizations have proposed several diagnostic
criteria [3–6]. However, finally, a consensus was established
by the International Diabetes Federation (IDF), National
Heart, Lung, and Blood Institute, American Heart Associ-
ation and other international societies [7].
MetS is a common condition and its worldwide preva-
lence is rising [8], which can be related to the increase in
obesity rates and sedentary lifestyles, as well as regional
prevalence of hypertension and diabetes. The prevalence
of overweight and obesity in Portugal is high [9] and is in-
creasing [10]. Overall, individuals with normal weight
(Wt) represent less than 50% of the adult population [10].
Recent studies have also shown a high prevalence of
hypertension and type 2 diabetes in the Portuguese popu-
lation (42.2% and 11.7%, respectively) [11, 12].
Previous national studies have shown the prevalence
of MetS, ranging from 42% to 66%, according to the IDF
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criteria [13–15]. However, none of them approached dis-
trict and urban versus non-urban differences.
The Portuguese Metabolic Syndrome (PORMETS)
study, was designed to assess the prevalence of MetS
and its determinants in the overall and administrative
regions of the Portuguese mainland.
Methods
PORMETS is a national cross-sectional study. A sample
of adults registered at primary health care centres
throughout mainland Portugal was selected. In each of
the eighteen Portuguese mainland administrative regions
(districts), two health care centres were included, one in
the district’s capital and the other representative of a
non-urban area. Apart from the district of Setubal that
only included one centre, all the others included two, for
a total of 35 health care centres. At each centre, the
participants were randomly selected from the general
practitioner’s patient lists, and 120 participants were
evaluated, with an inclusion criterion of being aged 18
or older. A total of 4105 participants was evaluated, and
information was collected from February 2007 to July
2009. Ten participants were excluded from the data ana-
lysis because they were pregnant at the time of the inter-
view, resulting in 4095 remaining participants. After
excluding participants who had missing information on
the MetS features, the final analysis included 4004 par-
ticipants, 2309 women and 1695 men.
All of the Portuguese Regional Health Administra-
tions, the Ethics Committee of the São João Hospital
E.P.E. and the Portuguese Data Protection Authority ap-
proved PORMETS. The Clinical Director of each health
care centre also provided authorization and all partici-
pants provided written informed consent.
Anthropometrics measures were recorded, namely Wt,
height, and waist and hip circumferences. Body Wt was
measured to the nearest 0.1 kg using a digital scale, and
height was measured to the nearest centimetre in the
standing position using a wall stadiometer. Body mass
index (BMI) was calculated as the Wt in kilogrammes
divided by the square height in metres. The waist cir-
cumference (WC) was measured midway between the
lower limit of the rib cage and the iliac crest and the hip
circumference (HC) was measured as the maximum cir-
cumference of the buttocks. Blood pressure was mea-
sured on a single occasion using a standard mercury
sphygmomanometer with the cuff on the upper right
arm after a 10-min rest. Two blood pressure readings
were taken, and the mean of the two readings was calcu-
lated. If the difference between the two measures was
larger than 5 mmHg for systolic or diastolic blood pres-
sure, a third measurement was acquired and the mean
of the two closest values was registered.
Fasting venous blood glucose, total cholesterol and tri-
glycerides levels were determined using automatic stand-
ard routine enzymatic methods. HDL-C was determined
after the precipitation of apolipoprotein B-containing li-
poproteins. All participants with triglycerides levels below
400 mg/dl had their LDL cholesterol level computed. This
value was estimated by subtracting the HDL- C value plus
20% of the triglycerides from the total cholesterol. High
sensitivity C-reactive protein (hs-CRP) levels were de-
termined using particle-enhanced immunonephelometry.
Insulin was measured using the 125I–labelled insulin
radioimmunoassay method, and insulin resistance was es-
timated according to the homeostatic model assessment
(HOMA), as the product of fasting glucose (mmol/L) and
insulin (μUI/mL) divided by a constant 22.5.
A trained nurse administered a structured questionnaire
with only closed ended questions; information was col-
lected on personal medical history and socio-demographic
and behavioural characteristics. A participant was consid-
ered a current smoker if he/she smoked daily or occasion-
ally, a former smoker was considered a participant who
had stopped smoking for at least six months, and a never
smoker was considered a participant who had never
smoked [16]. Regarding alcohol intake, the participants
were categorized as occasional drinkers if he/she had less
than a drink per day, daily drinker if he/she consumed, at
least one drink per day, and a non-drinker if he/she did
not consume any alcoholic beverages. Regular physical ex-
ercise was considered when the participant was engaged
in some leisure-time physical activity performed on a re-
peated basis, spending at least 30 min a week.
Portuguese regions were classified as North, Center,
Lisbon, Alentejo and Algarve according to the NUTS2
level statistical regions of the European Union.
Three operational definitions of MetS were used: the
Adult Treatment Panel III (ATP III) [4], IDF [5], and
HARM2009 [7]. MetS was considered present by ATP
III if at least three (any) of the following characteristics
were present: fasting glucose ≥110 mg/dL; blood pres-
sure ≥ 130/85 mmHg; triglycerides ≥150 mg/dL; HDL-
C < 40 mg/dL in women and <30 mg/dL in men;
WC > 88 cm in women and >102 cm in men. Partici-
pants who reported the use of antihypertensive or antidi-
abetic therapy were also considered as having the
corresponding MetS feature by the ATP III classification.
The considered IDF definition was WC ≥ 80 cm in
women and ≥94 cm in men and the presence of at least
two of the following characteristics: fasting glucose
≥100 mg/dL or previously diagnosed type 2 diabetes;
blood pressure ≥ 130/85 mmHg or antihypertensive
medication; triglycerides ≥150 mg/dL or current treat-
ment for this lipid abnormality; HDL-C < 40 mg/dL in
women and <30 mg/dL in men or current treatment for
this lipid abnormality. Finally, the HARM2009 defined
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MetS as the presence of at least three (any) of the following
characteristics: fasting glucose ≥100 mg/dL or antidiabetic
treatment; blood pressure ≥ 130/85 mmHg or antihyper-
tensive medication; triglycerides ≥150 mg/dL or specific
treatment for this lipid abnormality; HDL-C < 40 mg/dL in
women and <30 mg/dL in men or specific treatment for
this lipid abnormality; WC ≥ 88 cm in women and
≥102 cm in men (“European” cut off points).
Statistical analysis
The data are described as the mean values and standard
deviation (SD) or as median values and corresponding
25th and 75th percentiles for non-normally distributed
variables. Counts and proportions were reported for cat-
egorical variables. Proportions were compared using the
chi-square test or Fisher’s exact test, whenever appropri-
ate. Student’s t test or Mann-Whitney U-test was used
to compare continuous variables.
The prevalence of MetS and its individual components
was age and sex adjusted, using binomial generalized lin-
ear regression, with the log link function.
The prevalence and prevalence ratio (PR) of MetS and
their respective 95% confidence intervals (95%CI) were es-
timated for districts and NUT II by binomial generalized
linear regression, with the log link function. Each district
and NUT II region was compared with the overall effect,
obtained as the pooled geometric mean prevalence of all
districts, and the PR and respective 95%CI were calculated
using the deviation contrast method [17].
To estimate the magnitude of association between
MetS and demographic, socio-economic analytical and
lifestyle characteristics, the PR and 95%CI were also
computed using binomial generalized linear regression,
with the log link function. The p-values were obtained
using the Wald test from the respective generalized lin-
ear regressions.
Statistical analysis was performed using SPSS version 21 ®
and R version 8.0 software (R Foundation, Vienna, Austria).
Results
This study included 4004 individuals, 2309 women and
1695 men with a mean age of 53.2 (SD = 16.3) years.
The mean age was 54.1 (SD = 16.3) years in men and
52.6 (SD = 16.3) years in women (p = 0.004). The mean
(SD) levels of -glucose, triglycerides and HDL-C in
women and men were, respectively, 88.7 (25.4) / 115.1
(58.5) / 50.9 (11.8) and 96.5 (30.5) / 135.1 (85.0) / 43.8
(12.3) mg/dL. The mean (SD) values of WC were 90.9
(12.5) cm in women and 97.0 (11.4) cm in men. Systolic
and diastolic blood pressure values (mean and SD) were,
respectively, 129.1 (22.2) / 77.2 (12.1) mmHg in women
and 136.0 (21.8) / 79.8 (12.1) mmHg in men. Differences
between sexes were significant (p < 0.001) for all.
The prevalence rates of MetS in this sample of Portu-
guese adults adjusted for gender and age were 36.5%,
49.6% and 43.1% (crude prevalence rates of 32.7%, 45.9%
and 40.0%) using the ATPIII, IDF and HARM2009 defi-
nitions respectively (Table 1). The most prevalent feature
of MetS in this sample was “high blood pressure”
(64.3%) and the lowest was “high fasting glucose”
(24.9%). Most participants with MetS had 3 features
(23.3%). A minority had 5 features (4.9%). Significant dif-
ferences in gender were observed in the prevalence rates
of MetS (p < 0.001), MetS features (p < 0.001) and num-
ber of MetS features (p = 0.044). Women showed a
significantly higher prevalence of “high WC” and “low
HDL-C” components; all the other features were more
prevalent in men. The prevalence of the number of MetS
features also varied according to sex. The presence of
one or less components was higher in men, and the
presence of two to four components was higher in
women. Regarding the geographical distribution of MetS
and after adjustment for age and gender, significant dif-
ferences were observed for the 18 districts of the
Portugal mainland (Table 2); “Vila Real”, and “Leiria”
districts had a higher prevalence of MetS; however,
“Bragança” and “Beja” districts presented a lower preva-
lence. However, no differences were observed when we
compared the syndrome prevalence according to NUTS2
statistical regions, which establish a north-south division
of the country (Table 3).
In Table 4, results from the comparison between par-
ticipants with and without MetS are presented according
to demographic, behavioural, anthropometric and ana-
lytical characteristics. As expected, participants with
MetS had significantly higher mean values of Wt, BMI
and WC. Regarding analytical characteristics, partici-
pants with MetS had significantly higher mean levels of
glucose and triglycerides (p < 0.001). The insulin level
and HOMA were also significantly higher in participants
with MetS (p < 0.001). In addition, individuals with
MetS syndrome significantly reported a higher preva-
lence of previously diagnosed type 2 diabetes (p < 0.001),
myocardial infarction (p < 0.001) and stroke (p = 0.001).
MetS was significantly more frequent in women and
older subjects (p < 0.001). In addition, the syndrome was
more common in housewives (p = 0.010), retired
(p = 0.046) or unemployed (p = 0.024) participants.
However, MetS was less frequent in smokers (p = 0.001)
and in those that reported regular physical exercise
(p < 0.001).
When we compared the prevalence of the syndrome,
according to the classification of the health care centre
location in an urban/non-urban area, we found that
MetS was significantly (p = 0.001) more prevalent in
non-urban subjects after adjustment for sex and age
(PR:1.13;95%CI of 1.05 to 1.205). Non-urban residents
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were discretely older (mean age of 53.5 versus 52.9 years;
p = 0.229), presenting a slightly higher proportion of
men (44.0 versus 40.8%; p = 0.040) and had a lower edu-
cation level (mean of 6.0 versus 7.5 schooling years;
p < 0.001). After additional adjustment for the education
level, non-urban residents maintained a higher PR for
MetS (1.17; 95%CI of 1.06 to 1.29).
Discussion
The crude prevalence of MetS in our population-based
survey varied according to the definition used. The
HARM2009 definition, supported by several major orga-
nizations [7], is the most consensual. The ATP III and
IDF definitions have been widely used and may be useful
for comparisons of the prevalence of MetS between
studies. The prevalence was lowest according to the
ATP III definition (32.7%), followed by the HARM2009
definition (40%), and was highest when using the IDF
definition (45.9%). These differences were confirmed by
previous studies [13]. The cut-off points of the WC
component in the IDF setting were lower, and the cut-
off points of glycaemia in the ATP III definition were
higher than those using the HARM2009 definition.
The high prevalence of MetS is supported by previous
Portuguese studies [13–15]. A study in the city of Porto,
conducted during 1999–2003, and including a younger
population (mean age of 52.5 years) recruited with a
different methodology, estimated lower MetS crude
prevalence rates (24.0%, 41.9% and 27.6% according to
the ATP III, IDF and HARM2009 definitions, respect-
ively) [13]. Another national study [15], carried out be-
tween 2006 and 2007, with different selection criteria
and including an older population (mean age of
58.1 years), observed crude MetS prevalence rates of
28.4%, 65.5% and 69.4%, respectively, discretely higher
than those in the present study. The PREVADIAB study
conducted from 2008 to 2009 showed a crude pre-
valence of 41.5% by IDF criteria [14]. Nevertheless, the
national prevalence of MetS is higher than in some
European countries and the USA [8].
The high prevalence of MetS in the Portuguese popu-
lation may partly be explained by the decreasing adher-
ence of the Portuguese population to the Mediterranean
diet [18] and high prevalence of sedentary lifestyles,
namely in older adults [19], hypertension [11], obesity
[9] and type 2 diabetes [12].
Hypertension is highly prevalent among Portuguese
adults [11] but, as observed in other countries [20], a de-
creasing trend in the last decade was observed [21].
The prevalence of obesity in Portugal [9] and world-
wide [22] has risen to epidemic/pandemic proportions.
A systematic review on the prevalence of overweight
and obesity in Portugal (1995–2005) showed an in-
crease in the overweight prevalence by 3.2% and 3.5%
Table 1 Metabolic syndrome age-adjusted prevalence and its individual features according to different proposed definitions
n Total
[% (95%CI)]
Women
[% (95%CI)]
Men
[% (95%CI)]
p
MetS definition
ATP III 3986 36.5 (34.3–38.6) 38.8 (36.2–41.4) 33.5 (30.8–36.2) <0.001
IDF 3986 49.6 (47.5–51.7) 52.0 (49.5–54.5) 46.5 (43.9–49.1) <0.001
HARM2009 3987 43.1 (41.0–45.3) 45.7 (43.2–48.3) 39.8 (37.2–42.4) <0.001
MetS features a
Waist circumference 3977 51.0 (48.9–53.1) 66.2 (63.6–68.7) 35.7 (33.2–38.2) <0.001
Glucose 3965 24.9 (23.0–26.8) 20.8 (18.8–22.8) 32.0 (29.2–34.8) <0.001
Triglycerides 3980 29.4 (27.3–31.5) 24.7 (22.5–27.0) 37.2 (34.1–40.4) <0.001
HDL cholesterol 3984 56.5 (54.4–58.6) 61.2 (58.6–63.7) 50.6 (47.9–53.3) <0.001
Blood pressure 3984 64.3 (60.8–67.8) 60.6 (56.6–64.5) 69.7 (64.9–74.5) <0.001
Number of MetS features a
0 530 8.9 8.4 9.7
1 846 20.4 19.3 21.8
2 998 26.2 25.9 26.5
3 874 23.3 24.9 21.2
4 518 16.3 16.6 15.7
5 182 4.9 4.9 5.0
Mean (95%CI) 2.29 (2.23–2.35) 2.32 (2.26–2.39) 2.24 (2.17–2.31) 0.044
MetS: metabolic syndrome.
The PORMETS study was conducted in mainland Portugal from February 2007 to July 2009.
aMetabolic syndrome features defined according to HARM2009.
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and in the obesity prevalence by 7.4% and 1.3% among
women and men, respectively [10]. In addition, diabetes
is rising globally [23], and Portugal has one of the high-
est prevalence rates [12] compared with other European
countries [24].
Our study showed a higher prevalence of the “low
HDL-C” component than that reported in previous
MetS prevalence Portuguese studies [13, 25]. Neverthe-
less, a recent systematic review that summarizes the evi-
dence from Portuguese studies [26] showed mean HDL-
C values discretely higher than ours, for both sexes.
According to our data, the prevalence of the “high tri-
glycerides” component was discretely lower than that in
previous Portuguese studies [13, 25]. However, a system-
atic review [26] that quantified the distribution of lipid
fractions found mean triglycerides levels of 150 mg/dL
and 111 mg/dL in men and women respectively, similar
to our results.
The presence of MetS increases the risk of developing
CVD [1] and type 2 diabetes [2]. This study showed that
subjects with MetS significantly reported a higher preva-
lence of previously diagnosed type 2 diabetes, myocardial
infarction and stroke, suggesting the association of MetS
with CVD and diabetes. However, in Portugal, although
the prevalence of MetS is high, the age-adjusted mortal-
ity rates from CVD are low, namely when compared
Table 3 Metabolic syndrome prevalence (as defined by HARM2009) by Portuguese NUTS
NUTS II Prevalence (95%CI) Prevalence ratio (95%CI) Prevalence (95%CI) Prevalence ratio (95%CI)
Crude Adjusted for age and sex
North 40.0 (37.2–42.8) 0.98 (0.90–1.07) 45.0 (41.9–48.1) 0.96 (0.89–1.04)
Center 39.6 (37.1–42.2) 1.00 (0.93–1.07) 43.4 (40.5–46.3) 1.06 (0.99–1.13)
Lisbon 41.7 (37.5–45.8) 0.99 (0.92–1.06) 41.8 (37.7–45.9) 1.02 (0.96–1.08)
Alentejo 39.4 (35.6–43.2) 1.04 (0.95–1.13) 40.8 (40.0–44.6) 0.98 (0.91–1.06)
Algarve 39.8 (33.9–45.8) 0.99 (0.87–1.12) 41.6 (35.9–47.3) 0.96 (0.88–1.03)
Prevalence considering a 53.2-year mean age and a 42.2% proportion of men in the sample.
Reference class for prevalence ratio estimation:” Deviation coding” – comparison of the individual NUTS II with its global geometric mean.
The PORMETS study was conducted in mainland Portugal from February 2007 to July 2009.
Table 2 Metabolic syndrome prevalence (as defined by HARM2009) by Portuguese district
District Prevalence
(95%CI)
Prevalence ratio
(95%CI)
Prevalence
(95%CI)
Prevalence ratio
(95%CI)
Crude Adjusted for age and sex
Viana do Castelo 42.3 (35.8–48.8) 1.07 (0.91–1.23) 45.9 (39.6–52.1) 1.06 (0.92–1.20)
Braga 28.5 (22.7–34.2) 0.72 (0.59–0.86) 39.2 (32.1–46.2) 0.91 (0.75–1.07)
Vila Real 50.6 (44.2–57.0) 1.28 (1.12–1.44 55.1 (49.3–60.9) 1.27 (1.15–1.39)
Bragança 31.7 (25.8–37.6) 0.80 (0.66–0.95) 35.9 (29.7–42.1) 0.83 (0.70–0.97)
Porto 47.6 (41.1–54.1) 1.20 (1.04–1.37) 47.3 (41.4–53.2) 1.10 (0.97–1.22)
Aveiro 39.5 (33.2–45.8) 1.00 (0.85–1.16) 42.4 (36.2–48.7) 0.98 (0.85–1.11)
Viseu 29.4 (23.5–35.2) 0.74 (0.61–0.89) 38.4 (31.7–45.1) 0.89 (0.74–1.04)
Guarda 43.6 (37.2–49.9) 1.10 (0.95–1.26) 45.1 (39.1–51.1) 1.04 (0.91–1.17)
Coimbra 34.7 (28.7–40.7) 0.88 (0.74–1.03) 39.8 (33.4–46.1) 0.92 (0.78–1.06)
Leiria 48.0 (41.1–54.9) 1.21 (1.04–1.39) 50.7 (44.4–57.0) 1.17 (1.03.1.31)
Castelo Branco 44.0 (37.7–50.3) 1.11 (0.96–1.27) 44.7 (38.8–50.6) 1.04 (0.91–1.16)
Santarém 38.1 (31.9–44.3) 0.96 (0.82–1.12) 43.8 (37.5–50.1) 1.01 (0.88–1.15)
Lisbon 46.0 (39.7–52.3) 1.16 (1.01–1.32) 40.2 (34.7–45.7) 0.93 (0.81–1.05)
Portalegre 43.5 (36.0–50.9) 1.10 (0.92–1.28) 49.4 (42.5–56.2) 1.14 (0.97–1.30)
Évora 41.4 (35.2–47.7) 1.05 (0.90–1.20) 42.8 (37.0–48.6) 0.99 (0.86–1.12)
Setúbal 38.5 (26.6–50.3) 0.97 (0.70–1.26) 46.4 (34.9–58.0) 1.07 (0.80–1.33)
Beja 34.2 (28.1–40.4) 0.86 (0.72–1.02) 34.3 (28.3–40.2) 0.79 (0.67–0.92)
Faro 39.8 (33.9–45.8) 1.01 (0.86–1.16) 41.8 (36.1–47.5) 0.97 (0.84–1.09)
Prevalence considering a 53.2-year mean age and a 42.2% proportion of men in the sample.
Reference class for prevalence ratio estimation:” Deviation coding” – comparison of the individual districts with its global geometric mean.
The PORMETS study was conducted in mainland Portugal from February 2007 to July 2009.
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Table 4 Demographic, behavioural and analytical characteristics of the Metabolic Syndrome subjects
With MetS Without MetS Prevalence ratio (95%CI) a p
Gender Men 656 (39.0) 1026 (61.0) *
Women 938 (40.7) 1367 (59.3) 1.15 (1.07–1.23) < 0.001
Age [years, n (%)] 18–30 21 (5.0) 402 (95.0) *
31–40 87 (16.0) 458 (84.0) 3.20 (2.02–5.06) < 0.001
41–50 222 (30.5) 506 (69.5) 6.09 (3.96–9.37) < 0.001
51–60 391 (47.3) 435 (52.7) 9.52 (6.23–14.53) < 0.001
61–70 467 (58.5) 331 (41.5) 11.91 (7.82–18.15) < 0.001
> 70 406 (60.9) 261 (39.1) 12.40 (8.14–18.90) <0.001
Education [years, n (%)] 0–4 1054 (53.2) 929 (46.8) 1.11 (0.97–1.28) 0.137
5–12 415 (27.1) 1116 (72.9) 1.03 (0.89–1.20) 0.678
> 12 125 (26.4) 348 (73.6) *
Marital status Single/divorced/widower 377 (34.6) 713 (65.4) *
Married 1211 (41.9) 1676 (58.1) 0.99 (0.92–1.08) 0.869
Occupation [n (%)] Student 2 (2.4) 81 (97.6) 0.54 (0.14–2.09) 0.372
Unemployed 72 (36.2) 127 (63.8) 1.26 (1.03–1.53) 0.024
Housewife 195 (48.4) 208 (51.6) 1.23 (1.05–1.43) 0.010
Retired 703 (58.4) 500 (41.6) 1.16 (1.00–1.35) 0.046
Blue-collar 251 (29.4) 602 (70.6) 1.03 (0.81–1.20) 0.684
White-collar 193 (24.1) 607 (75.9) *
Smoking status [n (%)] Smoker 137 (24.2) 429 (75.8) 0.85 (0.73–0.98) 0.027
Ex-smoker 245 (42.8) 327 (57.2) 1.00 (0.90–1.11) 0.977
Non-smoker 1198 (43.1) 1580 (56.9) *
Physical exercise [n (%)] No 1232 (42.9) 1638 (57.1) 1.18 (1.08–1.29) <0.001
Yes 338 (31.9) 722 (68.1) *
Residence [n (%)] Non-urban 835 (43.4) 1087 (56.6) 1.13 (1.05–1.20) 0.001
Urban 759 (36.8) 1306 (63.2) *
Weight [kg, Mean (SE)] 78.5 (13.6) 68.1 (12.3) 1.00 (1.00–1.00) <0.001
Body mass index [kg/m2, Mean (SE)] 30.0 (4.4) 25.6 (4.0) 1.09 (1.08–1.10) <0.001
Waist circumference [cm, Mean (SE)] 101.4 (10.1) 88.2 (11.0) 1.00 (1.00–1.00) <0.001
Hip circumference [cm, Mean (SE)] 108.2 (9.4) 100.5 (8.5) 1.00 (1.00–1.00) <0.001
Total cholesterol [mg/dL, Mean (SE)] 211.6 (43.0) 207.1 (41.1) 1.04 (0.96–1.13) 0.305
HDL cholesterol [mg/dL, Mean (SE)] 43.2 (11.0) 51.0 (12.5) 0.81 (0.65–1.06) 0.067
Triglycerides [mg/dL, Mean (SE)] 159.0 (86.4) 99.8 (46.3) 1.28 (1.24–1.32) <0.001
Glucose [mg/dL, Mean (SE)] 105.5 (35.7) 83.1 (16.1) 1.11 (1.07–1.15) <0.001
Insulin [μU/ml, Median (P25 -P75)] 9.99 (6.80–14.30) 6.50 (4.40–9.50) 1.03 (1.03–1.04) <0.001
hs-CRP [mg/L, Median (P25 -P75)] 0.22 (0.10–0.47) 0.13 (0.06–0.29) 1.00 (1.00–1.00) 0.107
HOMA –IR [Median (P25 -P75)] 2.43 (1.58–3.72) 1.32 (0.86–1.96) 1.09 (1.07–1.10) <0.001
Diabetes [n (%)] 451 (76.8) 136 (23.2) 1.65 (1.55–1.75) < 0.001
Previous myocardial infarction [n (%)] 115 (69.3) 51 (30.7) 1.26 (1.14–1.40) <0.001
Previous stroke [n (%)] 138 (63.3) 80 (36.7) 1.19 (1.07–1.31) 0.001
MetS: metabolic syndrome (as defined by HARM2009).
The PORMETS study was conducted in mainland Portugal from February 2007 to July 2009.
aPrevalence ratio adjusted for sex and age.
*Reference class.
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with Western Europe countries [27], and have been de-
creasing in the last decade [28].
As expected, higher insulin levels and HOMA scores
were found in the individuals with MetS. These results
are supported by a previous study in the city of Porto
[29], stressing the contribution of insulin resistance to
the atherogenic profile of the syndrome [30].
According to our data, sedentary behaviour was asso-
ciated with a higher prevalence of MetS. These results
are supported by a recent meta-analysis [31].
Regarding this health problem in our societies, we
must consider not only biological but also socio-
demographic and psychosocial conditions. Some groups,
such as the elderly and the most socioeconomically dis-
advantaged have a higher risk of MetS [32]. Our data
showed an association of MetS with being a housewife,
retired or unemployed, corroborating findings from an-
other Portuguese study [33] and from other developed
countries [34, 35].
Some differences were found between districts but not
by regions of the Portugal mainland (NUTS II). In
addition, differences between urban and non-urban pop-
ulations in the prevalence of the MetS were observed,
with this condition being more frequent in non-urban
areas. The data from the 1999–2006 National Health
and Nutrition Examination Survey also showed that
non-urban dwelling was associated with a higher preva-
lence of MetS among adults in the United States [36].
This disparity, which was also found in other countries
[37], may be explained by demographic and socio-
economic factors [38]. However, these factors were ad-
dressed in this study and the differences persisted; other
explanations must be proposed.
Our study did not address the participants’ eating pat-
terns. We cannot exclude the contribution of the food
pattern to the differences found in some regions and
non-urban areas.
Given the increasing global burden of noncommunic-
able diseases such as diabetes and CVD, which is driven
by forces that include ageing and unhealthy lifestyles, the
estimation of the modifiable behavioural, metabolic and
physiological risk factors is essential. This study, when
documenting a high prevalence of metabolic syndrome in
Portugal, with all the risks involved, calls attention to the
need for an early diagnosis and therapeutic intervention.
The study also draws attention to at-risk groups that de-
serve special attention. These groups include those living
in non-urban areas or districts with a higher prevalence of
MetS. The elderly, women, the most disadvantaged socio-
economic categories and individuals with overweight or
sedentary lifestyles should also be considered.
Our study includes some strengths, namely the sample
size and selection of participants by districts and consid-
eration of urban and non-urban residence. Although our
study intends to be representative of the adult Portu-
guese population, we did not consider individuals not
enrolled at health centres belonging to the national
health system; however, all citizens have universal access
to the national health system. Another limitation of our
study was the lack of control of the participants’ eating
patterns.
Conclusions
This study showed that MetS is highly prevalent in the
Portuguese adult population. A high prevalence of hyper-
tension, obesity and diabetes in Portugal, may contribute
to these numbers.
Ageing [39] and the trend towards increasing obesity in
Portugal [10] are expected to contribute to a future in-
crease in MetS prevalence. Differences in the prevalence
of this syndrome were observed by district. In addition,
this condition was more frequent in non-urban areas.
These results may be useful in selecting priority sites for
future national intervention.
Our study provides valuable baseline information for
the development of future interventions in Portugal and
to assess the trends in the evolution of the MetS and as-
sociated risk factors.
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